Francesco Maura, Associate Director of Myeloma Research Institute at the University of Miami, shared a post on LinkedIn:
“Thanks Blood Journals Portfolio for inviting me and Juanjo Garces to write this commentary: ‘Time to say adieu to FISH in myeloma diagnostics’.
We summarize and comments on the the recent great effort from IMF, Jill Corre, Hervé Avet Loiseau showing how NGS DNA sequencing can replace FISH and provide more comprehensive characterization of newly diagnosed multiple myeloma.”
Title: Time to say adieu to FISH in myeloma diagnostics
Authors: Juan-Jose Garces, Francesco Maura
Read the Full Article in Blood.
Title: High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
Authors: Anaïs Schavgoulidze, Aurore Perrot, Xavier Leleu, Titouan Cazaubiel, Marie-Lorraine Chretien, Pierre Feugier, Karim Belhadj, Salomon Manier, Murielle Roussel, Sabine Brechignac, Frédérique Orsini-Piocelle, Mohamad Mohty, Jean-Marc Schiano de Collela, Margaret Macro, Didier Adiko, Mamoun Dib, Jean Fontan, Carine Luttiau-Motard, Didier Bouscary, Laurent Pascal, Virginie Roland, François Lifermann, Jana Bakala, Lydia Montes, Céline Kennel, Philippe Rey, Valentine Richez, Faiza Keddar, Laurent Frenzel, Claire Calmettes, Carine Chaleteix, Isabelle Plantier, Emilie Chalayer, Anna Schmitt, Christophe Roul, Hélène Demarquette, Chloe Cerutti, Luka Pavageau, Laure Derrier, Hervé Avet-Loiseau, Jill Corre
Read the Full Article in Blood.
More posts featuring Francesco Maura.